TD Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

TD Asset Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.1M	Buy	+192,500	New	+$17.3M	0.02%	515

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

MCM

Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

AWM

Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return

FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AFG

Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return

TD Asset Management's IHE Position: Q2 2026 in Review

TD Asset Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 192,500 shares worth $19.1M. The stake represents 0.02% of the portfolio and ranks #515 among its holdings.

93 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

TD Asset Management held 192,500 shares of iShares US Pharmaceuticals ETF worth $19.1M as of Q2 2026.
iShares US Pharmaceuticals ETF was a new TD Asset Management position in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.02% of TD Asset Management's portfolio in Q2 2026, its #515 holding.
93 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.